Recent evidence indicates that the selectively targeted exosome miR-148a-3p, functioning as a tumour suppressor across several malignancies (Feng et al., 2020a), may have a role in the negative regulation of MTF-1 in HCC, suggesting therapeutic advantages for HCC patients (Lyu et al., 2021). The gene discussed is MTF1; the disease is hepatocellular carcinoma.